AHPA continues to follow new COVID-19 regulations, guidance and other government actions. The updates below are the latest guidance and other developments since June 6, 2020 to help mitigate the impacts of COVID-19.

• CDC Updates Contact Tracing Guidelines
• FDA Revokes Emergency Use Authorization for Hydroxychloroquine
• Trump Administration Encourages Reopening of Health Care Facilities
• HHS Announces Fund Distribution Methodology
• FDA Revises Emergency Use Authorizations for Respirators
• OIG Strategic Plan: Oversight of COVID-19 Response and Recovery

Open document to read more; page 3.